Different expression of mu-opiate receptor in chronic and acute wounds and the effect of beta-endorphin on transforming growth factor beta type II receptor and cytokeratin 16 expression.

Bigliardi, P L; Sumanovski, L T; Büchner, S; Rufli, T; Bigliardi-Qi, M

Bigliardi, P L; Sumanovski, L T; Büchner, S; Rufli, T; Bigliardi-Qi, M.

Affiliation

Bigliardi PL; Department of Dermatology, University of Basel and Kantonsspital Schauffhausen, Switzerland. paul.bigliardi@kssh.ch

J Invest Dermatol ; 120(1): 145-52, 2003 Jan.

Article in En | MEDLINE | ID: mdl-12535211

Subject(s)

Gene Expression Regulation/drug effects; Keratins/genetics; Receptors, Opioid, mu/analysis; Receptors, Transforming Growth Factor beta/genetics; Wounds and Injuries/metabolism; beta-Endorphin/pharmacology; Acute Disease; Chronic Disease; Dose-Response Relationship, Drug; Humans; Organ Culture Techniques; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Wound Healing

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Wounds and Injuries / Beta-Endorphin / Gene Expression Regulation / Receptors, Transforming Growth Factor beta / Receptors, Opioid, mu / Keratins Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Invest Dermatol Year: 2003 Document type: Article

Search on Google

XML

PubMed Links